NASDAQ:ICU SeaStar Medical (ICU) Stock Price, News & Analysis $0.44 +0.01 (+2.31%) (As of 12/29/2023 ET) Add Compare Share Share Today's Range$0.42▼$0.4650-Day Range$0.37▼$1.0252-Week Range$0.16▼$6.34Volume1.61 million shsAverage Volume1.94 million shsMarket Capitalization$19.70 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media SeaStar Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside1,029.4% Upside$5.00 Price TargetShort InterestHealthy3.07% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.26Based on 4 Articles This WeekInsider TradingAcquiring Shares$40,000 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.50 out of 5 starsMedical Sector167th out of 950 stocksSurgical & Medical Instruments Industry18th out of 92 stocks 3.5 Analyst's Opinion Consensus RatingSeaStar Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $5.00, SeaStar Medical has a forecasted upside of 1,029.4% from its current price of $0.44.Amount of Analyst CoverageSeaStar Medical has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.07% of the float of SeaStar Medical has been sold short.Short Interest Ratio / Days to CoverSeaStar Medical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in SeaStar Medical has recently increased by 139.11%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSeaStar Medical does not currently pay a dividend.Dividend GrowthSeaStar Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ICU. Previous Next 2.4 News and Social Media Coverage News SentimentSeaStar Medical has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.84 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for SeaStar Medical this week, compared to 1 article on an average week.Search InterestOnly 5 people have searched for ICU on MarketBeat in the last 30 days. This is a decrease of -55% compared to the previous 30 days.MarketBeat Follows8 people have added SeaStar Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 60% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, SeaStar Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $40,000.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 4.50% of the stock of SeaStar Medical is held by insiders.Percentage Held by InstitutionsOnly 11.63% of the stock of SeaStar Medical is held by institutions. Previous Next N/A Earnings and Valuation Previous Next See Top Rated MarketRank™ Stocks Here About SeaStar Medical Stock (NASDAQ:ICU)SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver, Colorado.Read More ICU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ICU Stock News HeadlinesDecember 29, 2023 | msn.comSeaStar Medical builds enrolment in pivotal trial for AKI deviceDecember 28, 2023 | finance.yahoo.comSeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney InjuryDecember 31, 2023 | MarketBeat Internal (Ad)Claim Your $300 MarketBeat Account CreditClick the link below to claim your $300.00 account credit toward MarketBeat All Access. Pay just $99.00 for your 2024 MarketBeat All Access subscription (normally $399.00)December 22, 2023 | americanbankingnews.comComparing SeaStar Medical (NASDAQ:ICU) and Vivos (OTCMKTS:RDGL)December 22, 2023 | americanbankingnews.comAnalyzing SeaStar Medical (NASDAQ:ICU) & Vivos (OTCMKTS:RDGL)December 13, 2023 | finance.yahoo.comSeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical ExpertsNovember 23, 2023 | markets.businessinsider.comPromising Clinical Trials and Strong Financial Positioning Bolster Buy Rating Recommendation for SeaStar Medical HoldingsNovember 14, 2023 | finance.yahoo.comSeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business UpdateDecember 31, 2023 | MarketBeat Internal (Ad)New Year's Sale: Get MarketBeat All Access Free For 30 DaysAccess our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Click the link to claim your $300.00 account credit and free 30-day subscriptionNovember 1, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Reviva Pharmaceuticals Holdings (RVPH) and SeaStar Medical Holding (ICU)October 30, 2023 | marketwatch.comSeaStar Medical Shares Rise 13% After FDA Approvable LetterOctober 30, 2023 | msn.comSeaStar Medical gets Approvable Letter for SCD-PED deviceOctober 30, 2023 | finance.yahoo.comFDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric PatientsOctober 27, 2023 | benzinga.comWhy SeaStar Medical Holding Company Stock Is SoaringOctober 27, 2023 | msn.comSeaStar Medical rises 28%, withdraws equity offeringOctober 19, 2023 | msn.comWhat's Going On With Medical Devices Focused SeaStar Medical Stock Today?October 18, 2023 | marketwatch.comSeaStar Medical Shares Surge 52% on FDA Breakthrough DesignationOctober 18, 2023 | finance.yahoo.comFDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal SyndromeOctober 5, 2023 | finance.yahoo.comSeaStar Medical to Present at the Dawson James Small Cap Growth Conference on October 12, 2023October 3, 2023 | finance.yahoo.comSeaStar Medical Provides Regulatory Update Regarding Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device ExemptionSeptember 29, 2023 | marketwatch.comSeaStar Medical Shares Rise 36% After Breakthrough Device Designation for Selective Cytopheretic DeviceSeptember 29, 2023 | baystreet.caSeaStar Sails on FDA NodSeptember 29, 2023 | markets.businessinsider.comSeaStar Medical Reports Breakthrough Device Designation For Selective Cytopheretic DeviceSeptember 29, 2023 | finance.yahoo.comFDA Grants Breakthrough Device Designation to SeaStar Medical’s Selective Cytopheretic Device for Cardiorenal SyndromeAugust 29, 2023 | finance.yahoo.comCase Series of Three Critically Ill Children with Acute Kidney Injury Safely Treated with SeaStar Medical’s Selective Cytopheretic Device Published in the Journal Blood PurificationAugust 22, 2023 | finance.yahoo.comSeaStar Medical to Hold Business Update Conference Call Today at 4:00 p.m. Eastern TimeAugust 15, 2023 | finanznachrichten.deSeaStar Medical Holding Corporation: SeaStar Medical Reports Second Quarter 2023 Financial Results and Provides a Business UpdateSee More Headlines Receive ICU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SeaStar Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/14/2023Today12/31/2023Fiscal Year End12/31/2023Next Earnings (Estimated)4/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ICU CUSIPN/A CIK1831868 Webseastarmedical.com Phone844-427-8100FaxN/AEmployees9Year FoundedN/APrice Target and Rating Average Stock Price Target$5.00 High Stock Price Target$5.00 Low Stock Price Target$5.00 Potential Upside/Downside+1,029.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-23,010,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-961.93% Debt Debt-to-Equity RatioN/A Current Ratio0.18 Quick Ratio0.18 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.64) per share Price / Book-0.69Miscellaneous Outstanding Shares44,500,000Free Float42,498,000Market Cap$19.70 million OptionableNot Optionable Beta-1.22 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Eric Schlorff (Age 50)CEO, President & Executive Director Comp: $690kDr. H. David Humes M.D.Co-Founder and Managing DirectorMs. Caryl Baron (Age 56)Interim Chief Financial Officer Comp: $225kColonel Kevin Chung FACP (Age 50)M.D., Chief Medical Officer Comp: $375kTom MullenVice President of Operations & Product DevelopmentKey CompetitorsFemasysNASDAQ:FEMYSTRATA Skin SciencesNASDAQ:SSKNProSomnusNASDAQ:OSAT2 BiosystemsNASDAQ:TTOOBurgerFi InternationalNASDAQ:BFIView All CompetitorsInsiders & InstitutionsShaolin Capital Management LLCBought 25,000 shares on 12/20/2023Ownership: 0.000%Heel Kenneth VanBought 100,000 shares on 11/22/2023Total: $40,000.00 ($0.40/share)Shaolin Capital Management LLCBought 25,000 shares on 11/21/2023Ownership: 0.000%Kevin ChungBought 12,543 shares on 5/30/2023Total: $5,895.21 ($0.47/share)Richard D RussellBought 20,000 shares on 5/25/2023Total: $10,000.00 ($0.50/share)View All Insider TransactionsView All Institutional Transactions ICU Stock Analysis - Frequently Asked Questions Should I buy or sell SeaStar Medical stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SeaStar Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ICU shares. View ICU analyst ratings or view top-rated stocks. What is SeaStar Medical's stock price target for 2024? 1 equities research analysts have issued 1-year target prices for SeaStar Medical's shares. Their ICU share price targets range from $5.00 to $5.00. On average, they expect the company's share price to reach $5.00 in the next twelve months. This suggests a possible upside of 1,029.4% from the stock's current price. View analysts price targets for ICU or view top-rated stocks among Wall Street analysts. How have ICU shares performed in 2023? SeaStar Medical's stock was trading at $4.10 on January 1st, 2023. Since then, ICU stock has decreased by 89.2% and is now trading at $0.4427. View the best growth stocks for 2023 here. When is SeaStar Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, April 4th 2024. View our ICU earnings forecast. How were SeaStar Medical's earnings last quarter? SeaStar Medical Holding Co. (NASDAQ:ICU) issued its earnings results on Tuesday, November, 14th. The company reported ($0.12) earnings per share for the quarter. How do I buy shares of SeaStar Medical? Shares of ICU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ICU) was last updated on 12/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SeaStar Medical Holding Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.